Xiidra. Zaltrap. Gilotrif. Taltz.
What those words have in common, other than sounding like minor “Star Wars” characters, is that each is the name of a marketed drug. And, as such, each has been through the fantastic voyage by which humble molecules get white-boarded, focus-grouped, and lawyered-up on the way to having their names (and bountiful side effects) read aloud on the TV commercials that dot your nightly news.
About the Author Reprints
